| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3650497
[patent_doc_number] => 05605931
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-25
[patent_title] => 'Protective prostaglandins for use in conjunction with chemotherapeutic agents'
[patent_app_type] => 1
[patent_app_number] => 8/438802
[patent_app_country] => US
[patent_app_date] => 1995-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 6351
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/605/05605931.pdf
[firstpage_image] =>[orig_patent_app_number] => 438802
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/438802 | Protective prostaglandins for use in conjunction with chemotherapeutic agents | May 10, 1995 | Issued |
Array
(
[id] => 3603490
[patent_doc_number] => 05578640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-26
[patent_title] => 'Protective prostaglandins for use in conjunction with chemotherapeutic agents'
[patent_app_type] => 1
[patent_app_number] => 8/438814
[patent_app_country] => US
[patent_app_date] => 1995-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 6347
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/578/05578640.pdf
[firstpage_image] =>[orig_patent_app_number] => 438814
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/438814 | Protective prostaglandins for use in conjunction with chemotherapeutic agents | May 10, 1995 | Issued |
Array
(
[id] => 3555646
[patent_doc_number] => 05543411
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-06
[patent_title] => 'Hydroxylated metabolites and derivatives of doxazosin as anti-atherosclerosis agents'
[patent_app_type] => 1
[patent_app_number] => 8/436787
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1716
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/543/05543411.pdf
[firstpage_image] =>[orig_patent_app_number] => 436787
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436787 | Hydroxylated metabolites and derivatives of doxazosin as anti-atherosclerosis agents | May 7, 1995 | Issued |
Array
(
[id] => 3809275
[patent_doc_number] => 05811416
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate'
[patent_app_type] => 1
[patent_app_number] => 8/437462
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8426
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811416.pdf
[firstpage_image] =>[orig_patent_app_number] => 437462
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/437462 | Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate | May 7, 1995 | Issued |
Array
(
[id] => 3843236
[patent_doc_number] => 05708019
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Methods of treating hyperlipidemia using azaspirane derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/295777
[patent_app_country] => US
[patent_app_date] => 1995-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2759
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/708/05708019.pdf
[firstpage_image] =>[orig_patent_app_number] => 295777
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/295777 | Methods of treating hyperlipidemia using azaspirane derivatives | May 3, 1995 | Issued |
Array
(
[id] => 3620808
[patent_doc_number] => 05614507
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => 'Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia'
[patent_app_type] => 1
[patent_app_number] => 8/432691
[patent_app_country] => US
[patent_app_date] => 1995-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 4896
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614507.pdf
[firstpage_image] =>[orig_patent_app_number] => 432691
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/432691 | Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia | May 1, 1995 | Issued |
Array
(
[id] => 3657779
[patent_doc_number] => 05622985
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Method for preventing a second heart attack employing an HMG CoA reductase inhibitor'
[patent_app_type] => 1
[patent_app_number] => 8/424984
[patent_app_country] => US
[patent_app_date] => 1995-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5516
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622985.pdf
[firstpage_image] =>[orig_patent_app_number] => 424984
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/424984 | Method for preventing a second heart attack employing an HMG CoA reductase inhibitor | Apr 18, 1995 | Issued |
Array
(
[id] => 3588679
[patent_doc_number] => 05550164
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Method for inhibiting uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/416260
[patent_app_country] => US
[patent_app_date] => 1995-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3827
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550164.pdf
[firstpage_image] =>[orig_patent_app_number] => 416260
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/416260 | Method for inhibiting uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives | Apr 3, 1995 | Issued |
Array
(
[id] => 3609522
[patent_doc_number] => 05534242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-09
[patent_title] => 'Lidocaine-vasoconstrictor aerosol preparation'
[patent_app_type] => 1
[patent_app_number] => 8/408877
[patent_app_country] => US
[patent_app_date] => 1995-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4007
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/534/05534242.pdf
[firstpage_image] =>[orig_patent_app_number] => 408877
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408877 | Lidocaine-vasoconstrictor aerosol preparation | Mar 23, 1995 | Issued |
Array
(
[id] => 3696025
[patent_doc_number] => 05661158
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Use of angiotensin II antagonists for the treatment of hyperlipidemia'
[patent_app_type] => 1
[patent_app_number] => 8/381885
[patent_app_country] => US
[patent_app_date] => 1995-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4262
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661158.pdf
[firstpage_image] =>[orig_patent_app_number] => 381885
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/381885 | Use of angiotensin II antagonists for the treatment of hyperlipidemia | Mar 22, 1995 | Issued |
Array
(
[id] => 3665549
[patent_doc_number] => 05597818
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-28
[patent_title] => 'Methods of treating cardiac arrhythmia'
[patent_app_type] => 1
[patent_app_number] => 8/407337
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25069
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/597/05597818.pdf
[firstpage_image] =>[orig_patent_app_number] => 407337
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/407337 | Methods of treating cardiac arrhythmia | Mar 19, 1995 | Issued |
| 08/407733 | METHOD FOR PREVENTING ONSET OF RESTENOSIS AFTER ANGIOPLASTY EMPLOYING A RETINOID | Mar 19, 1995 | Abandoned |
Array
(
[id] => 3588706
[patent_doc_number] => 05550166
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Pinitol and derivatives thereof for the treatment of metabolic disorders'
[patent_app_type] => 1
[patent_app_number] => 8/407430
[patent_app_country] => US
[patent_app_date] => 1995-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5128
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550166.pdf
[firstpage_image] =>[orig_patent_app_number] => 407430
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/407430 | Pinitol and derivatives thereof for the treatment of metabolic disorders | Mar 16, 1995 | Issued |
Array
(
[id] => 3519827
[patent_doc_number] => 05530001
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Pharmaceutical use of dihydropyridine derivative'
[patent_app_type] => 1
[patent_app_number] => 8/360705
[patent_app_country] => US
[patent_app_date] => 1995-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8929
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530001.pdf
[firstpage_image] =>[orig_patent_app_number] => 360705
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/360705 | Pharmaceutical use of dihydropyridine derivative | Feb 23, 1995 | Issued |
Array
(
[id] => 3587292
[patent_doc_number] => 05552413
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Methods for inhibiting hyperproliferation of kerntinocytes'
[patent_app_type] => 1
[patent_app_number] => 8/391760
[patent_app_country] => US
[patent_app_date] => 1995-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3126
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552413.pdf
[firstpage_image] =>[orig_patent_app_number] => 391760
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/391760 | Methods for inhibiting hyperproliferation of kerntinocytes | Feb 20, 1995 | Issued |
Array
(
[id] => 3530783
[patent_doc_number] => 05583143
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => 'Methods for inhibiting calmodulin activity'
[patent_app_type] => 1
[patent_app_number] => 8/392451
[patent_app_country] => US
[patent_app_date] => 1995-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3137
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/583/05583143.pdf
[firstpage_image] =>[orig_patent_app_number] => 392451
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392451 | Methods for inhibiting calmodulin activity | Feb 20, 1995 | Issued |
| 08/389821 | METHODS FOR TREATING COCCIDIOSIS | Feb 14, 1995 | Abandoned |
Array
(
[id] => 3691393
[patent_doc_number] => 05660855
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Lipid constructs for targeting to vascular smooth muscle tissue'
[patent_app_type] => 1
[patent_app_number] => 8/386579
[patent_app_country] => US
[patent_app_date] => 1995-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9340
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/660/05660855.pdf
[firstpage_image] =>[orig_patent_app_number] => 386579
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/386579 | Lipid constructs for targeting to vascular smooth muscle tissue | Feb 9, 1995 | Issued |
Array
(
[id] => 3861913
[patent_doc_number] => 05795881
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type'
[patent_app_type] => 1
[patent_app_number] => 8/385801
[patent_app_country] => US
[patent_app_date] => 1995-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3109
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795881.pdf
[firstpage_image] =>[orig_patent_app_number] => 385801
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/385801 | Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type | Feb 8, 1995 | Issued |
Array
(
[id] => 3496933
[patent_doc_number] => 05532251
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-02
[patent_title] => 'Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazabicyclo[3.3.1]nonane compounds'
[patent_app_type] => 1
[patent_app_number] => 8/382265
[patent_app_country] => US
[patent_app_date] => 1995-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3614
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/532/05532251.pdf
[firstpage_image] =>[orig_patent_app_number] => 382265
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/382265 | Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazabicyclo[3.3.1]nonane compounds | Jan 31, 1995 | Issued |